Description
Epstein-Barr virus (EBV) belongs to the herpesviruses and is one of the most common viruses among the adult population. The main goal of diagnosis is to differentiate between acute and past infection. The immune response in EBV infection is characterized by the formation of antibodies to capsid (EBV-CA), nuclear (EBNA), and early (EBV–EA) EBV antigens. At the early stage of the disease, IgM and IgG antibodies to the viral capsid antigen are detected. IgG antibodies to the early antigen are produced later during the acute stage of the disease and disappear after 3-6 months. In turn, IgG antibodies to the capsid antigen persist throughout life. Antibodies to the Epstein-Barr virus nuclear antigen are produced within 6-8 weeks after infection. The presence of these antibodies indicates a past infection. The test is intended for the detection of IgG antibodies in blood serum for the diagnosis of diseases caused by EBV (infectious mononucleosis, Burkitt's lymphoma, nasopharyngeal carcinoma).
Period of execution
Within 8 days. The specified time does not include the day of biomaterial collection
Biomaterial type